ScholarIQanswers from OpenAlex & ORCID
Miquel Tarón
ResearcherPublications, citations & collaboration network
Miquel Tarón is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Miquel Tarón have?
ScholarIQindexed works
Miquel Tarón has 305 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Miquel Tarón have?
ScholarIQcitation count
Miquel Tarón has 19,478 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Miquel Tarón?
ScholarIQh-index
Miquel Tarón has an h-index of 54 in OpenAlex.
What is the i10-index of Miquel Tarón?
ScholarIQi10-index
Miquel Tarón has an i10-index of 111 in OpenAlex.
What is the OpenAlex record for Miquel Tarón?
ScholarIQopenalex
The OpenAlex for Miquel Tarón is on the source record.
What are the most-cited papers on Miquel Tarón?
ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D. Levine, Jin Kyung Rho, Yun Jung Choi, Chang‐Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung‐Shin Lee, Vincent A. Miller, Maria E. Arcila, Marc Ladanyi, Philicia Moonsamy, Charles L. Sawyers, Titus J. Boggon, C. Patrick, Carlota Costa, Miquel Tarón, Rafael Rosell, Balázs Halmos, Trever G. Bivona
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Juan Sandoval, Jesús Méndez‐González, Ernest Nadal, Guoan Chen, F. Javier Carmona, Sergi Sayols, Sebastián Morán, Holger Heyn, Miguel Vizoso, Antonio Gómez, Montse Sánchez‐Céspedes, Yassen Assenov, Fabian Müller, Christoph Bock, Miquel Tarón, Josefina Móra, Lucia Anna Muscarella, Triantafillos Liloglou, Michael P.A. Davies, Marina Pollán, María J. Pajares, W. Torre, Luis M. Montuenga, Élisabeth Brambilla, John K. Field, Luca Roz, Marco Lo Iacono, Giorgio V. Scagliotti, Rafael Rosell, David G. Beer, Manel Esteller